Asthma Clinical Trials in Chicago

Showing 381-400 of 427 trials

Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants

NCT00152542

Our previous data demonstrated that premature infants treated with inhaled nitric oxide at birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to determine whether this benefit continues through school age.

Prematurity, Respiratory Distress Syndrome,Hypoxemia

University of Chicago160 participantsStarted May 2005

Chicago, Illinois, United States

COMPLETED2.2 miles

ICATA Asthma Mechanistic Study

NCT00377390

The purposes of this study are to determine the effects of omalizumab on cells involved in the allergic response, to evaluate predictors of response to omalizumab, and to determine whether response to omalizumab therapy is influenced by the environment. A subset of inner-city children and adolescents currently enrolled in Inner-City Anti-IgE Therapy for Asthma (a clinical trial of omalizumab) will be enrolled in this study.

Asthma

National Institute of Allergy and Infectious Diseases (NIAID)224 participantsStarted Oct 2006

Chicago, Illinois, United States • New York, New York, United States • Cleveland, Ohio, United States +1 more locations

COMPLETEDPhase 32.2 miles

Study of Acid Reflux in Asthma

NCT00069823

The purpose of this study is to determine if subjects with symptomatic asthma who are assigned to treatment with a proton pump inhibitor (PPI) drug such as Nexium have fewer asthma attacks than similar subjects assigned to placebo treatment.

AsthmaLung DiseasesLung Diseases, Obstructive

Johns Hopkins Bloomberg School of Public Health403 participantsStarted Sep 2003

Birmingham, Alabama, United States • San Diego, California, United States • Denver, Colorado, United States +17 more locations

Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants

ICATA Asthma Mechanistic Study

Study of Acid Reflux in Asthma

Asthma Trials in Other Cities

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

Coping Peer Intervention for Adherence

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

The Community United to Challenge Asthma

Calfactant for Direct Acute Respiratory Distress Syndrome

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Evaluation Montelukast in the Treatment of Status Asthmaticus

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Acute Cough Study In Children

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

Sofia RSV FIA Field Study

Other Conditions in Chicago